Status:
COMPLETED
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Lead Sponsor:
Azienda Ospedaliero-Universitaria di Modena
Conditions:
Pancreas Neoplasms
Liver Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
The study focuses on patients with synchronous liver metastasis from pancreatic adenocarcinoma that underwent both pancreatic and liver resection. The control group is made up of patients with resecta...
Detailed Description
1. Summary: The study focuses on patients with synchronous liver metastasis from pancreatic adenocarcinoma that underwent both pancreatic and liver resection. The control group is made up of patie...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients of age \>18, underwent surgery for pancreatic adenocarcinoma (duodenopancreatectomy, distal pancreatectomy, total pancreatectomy) and liver resection (major or minor) for synchronous metastasis, that received neoadjuvant and/or adjuvant chemotherapy.
- The control group is made up of patients age \>18 with resectable or borderline resectable pancreatic adenocarcinoma and synchronous liver metastasis that didn't underwent surgery.
Exclusion
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06980792
Start Date
June 1 2022
End Date
December 31 2024
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU di Modena
Modena, Italy, 41124